Combination low‐dose lymphoblastoid interferon and thymosin α₁ therapy in the treatment of chronic hepatitis B

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1993 • 1,011 citations

A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis B

1990 • 855 citations

The chemistry and biology of thymosin. I. Isolation, characterization, and biological activities of thymosin alpha1 and polypeptide beta1 from calf thymus.

1979 • 268 citations

Clinical Pharmacokinetics of Interferons

1990 • 245 citations

Neutralizing Antibodies to Interferon- : Relative Frequency in Patients Treated with Different Interferon Preparations

1991 • 214 citations

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

1992 • 161 citations

Thymosin treatment of chronic hepatitis B: A placebo-controlled pilot trial

1991 • 134 citations

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon

1992 • 108 citations

Genetic variation in hepatitis B virus

1992 • 85 citations

Treatment of chronic hepatitis B

1994 • 65 citations

Relationship between histology, aminotransferase levels, and viral replication in chronic hepatitis B

1990 • 46 citations

Comparative study of three doses of interferon‐α2a in chronic active hepatitis B

1994 • 35 citations

Therapy for chronic hepatitis B with lymphoblastoid interferon-α and levamisole

1992 • 30 citations

Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents

1994 • 25 citations

Human lymphoblastoid interferon for the treatment of chronic hepatitis B. A randomized controlled trial.

1988 • 10 citations

Utilization of HPLC-Elisa to Assess Serum Levels of Thymosin α¹Following Subcutaneous Administration to Human Subjects

1994 • 7 citations